Fundraising Fox
🦊/People
Sign in

John Hamer

Investor

Managing Partner, DCVC Bio at DCVC Bio · Managing Partner, DCVC Bio at DCVC (Data Collective) · Board director at Avicenna Biosciences · Board director at Umoja Biopharma, Inc. · Board director at Pivot Bio

San Francisco, California

Writes $5M – $25M checks · typically $15M

Find your path to John

334 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

Charles CallunlockedJohn: together at University of California, Davis (1986–1987)
John: together at University of California, Davis Graduate School of Management
John: together at Burrill & Company
John: together at DCVC (Data Collective)

About

Co-founder and Managing Partner of DCVC Bio, focused on computational biology and life sciences investments.

Contact· self-published, not guessed

Likely emails· guessed from name + firm domain, not firm-published

Invests in

BiotechClimate TechData & InfrastructureDeep TechHardwareHealthtech

Beyond investing

Education
Studied at UC Berkeley (Electrical Engineering and Computer Science)

From published sources — common ground for a warm intro.

Board director at Avicenna Biosciences

Intro paths

→

In turn, John can intro founders to Avicenna Biosciences's investors below.

Avicenna Biosciences's investors · 1

DCVC BioPalo Alto · since 2025

Board director at Umoja Biopharma, Inc.

Intro paths

→

In turn, John can intro founders to Umoja Biopharma, Inc.'s investors below.

Umoja Biopharma, Inc.'s investors · 7

DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2021DCVC BioPalo Alto · since 2021K2 HealthVenturesBoston · $10M – $100M checks · since 2021MPM BioImpactBoston · $1M – $15M checks · since 2021Qiming Venture Partners USACambridge · since 2021SoftBank GroupTokyo · since 2021SoftBank Vision FundLondon · since 2021

Co-founders at Umoja Biopharma, Inc.

AM
Andrew M. ScharenbergExecutive Officer, Director

Board director at Pivot Bio

Intro paths

→

In turn, John can intro founders to Pivot Bio's investors below.

Pivot Bio's investors · 13

Breakthrough Energy VenturesBoston · $500K – $50M checks · since 2018Congruent VenturesSan Francisco · $100K – $5M checksDCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2016G2 Venture PartnersPortola Valley · $15M – $25M checksK3 VenturesSingapore · $1.2M – $42M checksManta Ray VenturesLondonNational Science FoundationAlexandria · since 2015OS FundPark Ridge · $1M – $2M checksPrelude VenturesSan Francisco · $100K – $5M checksRaptor GroupMiami BeachSpruce Capital PartnersSouth San FranciscoTekfen VenturesNew York · $1M – $3M checksTemasekSingapore

Co-founders at Pivot Bio

ATAlvin Tamsir
Alvin TamsirExecutive Officer, Director
KTKarsten Temme
Karsten TemmeExecutive Officer, Director

Experience

  1. DCVC BioManaging Partnercurrent2018 — present500 2nd Street San Francisco CA
  2. University of California, Davis Graduate School of ManagementInvited Lecturercurrent2009 — present
  3. CIATBoard of Trustee2012 — 2018Cali, Colombia
  4. MonsantoMonsanto Growth Ventures2012 — 2018San Francisco Bay Area
  5. Chromatin, Inc.Chairperson2008 — 2012Greater Chicago Area
  6. Burrill & CompanyManaging Director2003 — 2011
  7. Arete TherapeuticsCEO2003 — 2006
  8. Paradigm Genetics (Icoria)CSO, CEO, VP Business Development1998 — 2003
  9. Purdue UniversityProfessor of Biological Sciences1988 — 2000
  10. Academic Press Inc.Editor-In-Chief, Fungal Genetics and Biology1993 — 1999
  11. DuPontVisiting Scientist1987 — 1989

Skills & more

Biofuels17Lifesciences79Microbiology30Venture Capital67BiotechnologyDrug Development15Genomics54Genetics43Agriculture18Science25Biochemistry10Bioinformatics3
+8 moreBiomarkersBiopharmaceuticalsBusiness DevelopmentChemistryClinical DevelopmentClinical TrialsCommercializationCorporate Development

From John's professional profile.

Investments

Investor

AgbiomeAgSolverAtomwiseBioceres S.A.BioPheroBlue River TechnologiesCH4 GlobalCoverCressHydroBioPivot BioSidewinder TherapeuticsSolu TherapeuticsTotus MedicinesTranslate Bio

Per curated public sources.

Colleagues at DCVC Bio

Aimee Villamayor
Office Manager & Executive Assistant, DCVC Bio at DCVC Bio
Carly Smith
Office Assistant, DCVC Bio at DCVC Bio
Christopher Meldrum
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Dr. Adil Anjem
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Dr. Andy May
Operating Partner, DCVC Bio at DCVC Bio
Dr. Emily Park
Principal, DCVC Bio at DCVC Bio
Dr. John Hamer
Managing Partner, DCVC Bio at DCVC Bio
Dr. Justin Kern
Partner, DCVC Bio at DCVC Bio

Frequently asked questions

Who is John Hamer?
Co-founder and Managing Partner of DCVC Bio, focused on computational biology and life sciences investments.
Where does John Hamer work?
John Hamer is Managing Partner, DCVC Bio at DCVC Bio and Board director at Avicenna Biosciences and Board director at Umoja Biopharma, Inc. and Board director at Pivot Bio.
What does John Hamer invest in?
John Hamer invests in Biotech, Climate Tech, Data & Infrastructure, Deep Tech, Hardware, Healthtech.
What check size does John Hamer write?
John Hamer typically writes checks of $5M – $25M.
What companies has John Hamer invested in?
Investments tracked here include Agbiome, AgSolver, Atomwise, Bioceres S.A., BioPhero, Blue River Technologies, CH4 Global, CoverCress, HydroBio, Pivot Bio, Sidewinder Therapeutics, Solu Therapeutics, and 2 more.
Where did John Hamer go to school?
John Hamer studied at University of California, Davis (Ph.D, Microbiology); University of Windsor (M.Sc., Biological Sciences); University of Windsor (B.Sc., Biology).

Same school

Shared employers